Assessment | Baseline visit (T = 0) | During intervention | Follow-up visit (T = 12) |
---|---|---|---|
Physical activity level | |||
Step count with STEPWISE app (primary outcome) | x | ||
Physical activity with Axivity AX6 | x (1 week) | x (1 week) | |
Self-reported physical activity level | x | x | |
Physical fitness | |||
6 minute walk test (6MWT) Cardiopulmonary exercise test (subgroup of 100 people) Remote cardiorespiratory fitness with mPower app ** | x x x | x x x (1 day/3months) | x x x |
Motor symptoms | |||
Timed Up and Go Test (TUG) Mini-BestTest MDS-UPDRS III (in on-state) MDS-UPDRS IV 10MWT (gait speed) Handgrip strength | x x x x x x | x x x x x x | |
Falls and near falls | x | X (monthly fall diary) | x |
Falls Efficacy Scale - International (FES-I) * Lichamelijke Vaardigheden Schaal (LIVAS) * | x x | x x | |
Motor functioning with mPower app ** | x | x (14days/3months) | x |
Non-motor symptoms | |||
Montreal Cognitive Assessment (MoCA) Hamilton Anxiety and Depression Scale (HADS) * Abbreviated version of the Apathy Evaluation Scale (AES-12PD) * Scales for Outcomes in Parkinson’s Disease (SCOPA) * Fatigue Severity Scale (FSS) * MDS-UPDRS I and II * | x x x x x x | x x x x x x | |
Quality of life | |||
Parkinson’s Disease Questionnaire (PDQ-39) * | x | x | |
Other | |||
Custom questionnaire on blinding | x | ||
Global Perceived Effect (GPE) * Custom questionnaire on barriers and motivators to engage in | x x | x x | |
physical activity |